Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Pharmaceuticals Market

PRODUCT TITLE PUBLISHED
Clinical Outsourcing Services Clinical Outsourcing Services
Clinical Outsourcing Services and Manufacturing Outsourcing Services,
Upcoming
Manufacturing Outsourcing Services Manufacturing Outsourcing Services
Manufacturing Outsourcing Services and Clinical Outsourcing Services,
Upcoming
Discovery Outsourcing Services Discovery Outsourcing Services
Discovery Outsourcing Services and Clinical Outsourcing Services,
Upcoming
Preclinical models Preclinical models
Preclinical models and Clinical Outsourcing Services,
Upcoming
Cell-Based Assays Cell-Based Assays
Cell-Based Assays and Clinical Outsourcing Services,
Upcoming
Global Oral Drug Delivery Market Global Oral Drug Delivery Market
The Global Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $64.3 billion in 2013 and expected to be $100.8 billion by 2018, growing at a CAGR of 9.4%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Global Transmucosal Drug Delivery Market Global Transmucosal Drug Delivery Market
The Global Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.91 billion in 2013 and expected to be $4.05 billion by 2018, growing at a CAGR of 6.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Global Topical Drug Delivery Market Global Topical Drug Delivery Market
The Global Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.44 billion in 2013 and expected to be $11.21 billion by 2018, growing at a CAGR of 3.5%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
Global Nasal Drug Delivery Devices Market Global Nasal Drug Delivery Devices Market
The Global Nasal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.94 billion in 2013 and expected to be $15.02 billion by 2018, growing at a CAGR of 8.6%. The Nasal Drug Delivery Devices Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
Ocular Drug Delivery Ocular Drug Delivery
Ocular Drug Delivery and Oral Drug Delivery,
Upcoming
Biosimilars Biosimilars
Biosimilars and Chromatography, E-Clinical Trial...
Upcoming
Drug Discovery Services Drug Discovery Services
Drug Discovery Services and Preclinical Services,
Upcoming
Preclinical Services Preclinical Services
Preclinical Services and Drug Discovery Services,
Upcoming
Clinical Development Phase I Clinical Development Phase I
Clinical Development Phase I and Drug Discovery Services,
Upcoming
Clinical Development Phase II Clinical Development Phase II
Clinical Development Phase II and Drug Discovery Services,
Upcoming
Clinical Development Phase III Clinical Development Phase III
Clinical Development Phase III and Drug Discovery Services,
Upcoming
Clinical Development Phase IV Clinical Development Phase IV
Clinical Development Phase IV and Drug Discovery Services,
Upcoming
Clinical data management & Biostatistics Services Clinical data management & Biostatistics Services
Clinical data management & Biostatistics Services and Drug Discovery Services,
Upcoming
Medical Writing Services Medical Writing Services
Medical Writing Services and Drug Discovery Services,
Upcoming
Regulatory Services Regulatory Services
Regulatory Services and Drug Discovery Services,
Upcoming
812 reports | Show
Connect With Us
US/CAN : +1-888-502-0539